Wasatch Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $271M | Sell |
|
|||||
|
2024
Q3 | $282M | Buy |
|
|||||
|
2024
Q2 | $255M | Sell |
|
|||||
|
2024
Q1 | $267M | Buy |
|
|||||
|
2023
Q4 | $260M | Sell |
|
|||||
|
2023
Q3 | $198M | Buy |
|
|||||
|
2023
Q2 | $221M | Sell |
|
|||||
|
2023
Q1 | $243M | Sell |
|
|||||
|
2022
Q4 | $251M | Sell |
|
|||||
|
2022
Q3 | $244M | Sell |
|
|||||
|
2022
Q2 | $308M | Sell |
|
|||||
|
2022
Q1 | $458M | Sell |
|
|||||
|
2021
Q4 | $431M | Buy |
|
|||||
|
2021
Q3 | $303M | Buy |
|
|||||
|
2021
Q2 | $266M | Sell |
|
|||||
|
2021
Q1 | $221M | Buy |
|
|||||
|
2020
Q4 | $201M | Buy |
|
|||||
|
2020
Q3 | $139M | Buy |
|
|||||
|
2020
Q2 | $94M | Buy |
|
|||||
|
2020
Q1 | $45.1M | Buy |
|
|||||
|
2019
Q4 | $61.1M | Sell |
|
|||||
|
2019
Q3 | $30M | Buy |
|
|||||
|
2019
Q2 | $30.5M | Sell |
|
|||||
|
2019
Q1 | $28.8M | Buy |
|
|||||
|
2018
Q4 | $22.6M | Buy |
|
|||||
|
2018
Q3 | $41.8M | Buy |
|
|||||
|
2018
Q2 | $33.7M | Buy |
|
|||||
|
2018
Q1 | $39.6M | Sell |
|
|||||
|
2017
Q4 | $27.9M | Sell |
|
|||||
|
2017
Q3 | $31.1M | Buy |
|
|||||
|
2017
Q2 | $20.6M | Buy |
|
|||||
|
2017
Q1 | $16.3M | Sell |
|
|||||
|
2016
Q4 | $15.3M | Buy |
|
|||||
|
2016
Q3 | $11.5M | Sell |
|
|||||
|
2016
Q2 | $31.5M | Buy |
|
|||||
|
2016
Q1 | $22.2M | Buy |
|
|||||
|
2015
Q4 | $42.6M | Sell |
|
|||||
|
2015
Q3 | $43.5M | Sell |
|
|||||
|
2015
Q2 | $36.1M | Buy |
|
|||||
|
2015
Q1 | $23.9M | Buy |
|